Agenda

• Moderator Introduction: Patrick Collier, MD
• Case Presentation: Erika Hutt Centeno, MD
• Cardiac Evaluation: Imaging & Biomarkers: Patrick Collier, MD
• Oncology Perspective: Evaluation & Screening: Dale Shepard, MD, PhD
• Management of Cardiac Issues During & After Treatment: Rohit Moudgil, MD, PhD
• Incidence of Afib: the Role of EP: Mohamed Kanj, MD
• Heart Failure in Cancer Patients: W.H. Wilson Tang, MD
• Cardiac Tumors: Surgical Considerations: Michael Tong, MD

Learning Objectives:

• Define the risks of cancer treatment-related cardiac dysfunction for patients who have undergone therapy for cancer.
• Identify cardiovascular effects of newer cancer therapies.
• *Describe strategies for long-term cardiovascular monitoring in order to reduce the effects of cardiotoxicity, for patients who are at risk for cancer treatment-related cardiac dysfunction.

Complete CME process to claim your credit

Target Audience

This online series is designed for physicians, allied health practitioners and students interested in complex cardiovascular and thoracic conditions.

Accreditation Statement

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic. In no event will The Cleveland Clinic be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are Free of commercial bias.

The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Jeanna Sigmund, MSN, Erika Hutt, MD, Rohit Moudgil, BSC, Patrick Collier, MD, Kathleen Breznai.

The following faculty has indicated that they may have a relationship, which in the context of their presentation(s) could be perceived as a potential conflict of interest: Eric E Roselli, MD, Activity Director: Cook Medical - Teaching and Speaking. Artivion - Consulting. Terumo - Teaching and Speaking. W.L. Gore & Associates - Consulting. Medtronic - Consulting. Edwards Lifesciences - Teaching and Speaking. Abbott - Teaching and Speaking. LivaNova, PLC - Consulting, Teaching and Speaking. Mohamed Kanj, MD: Boston Scientific Corporation - Teaching and Speaking. Dale Shepard, MD, PhD: Astellas Pharma US, Inc. - Research. Bayer Healthcare - Research. Novartis - Research. Genzyme/Sanofi – Other activities from which remuneration is received or expected. Deciphera Pharmaceuticals - Teaching and Speaking. Replimune - Consulting, Advisor or review panel participant. Harpoon - Research. InhibRx - Research. Rain - Research. Compugen - Research. Vigeo - Research. Mabspace Bioscience - Research. Vascular Biogenics Ltd. - Research. Aadi - Research. Hummingbird - Research. Cogent - Research. Michael Tong, MD: Abiomed - Consulting, Teaching and Speaking. Abbott - Consulting, Teaching and Speaking. W. H. Wilson Tang, MD:

For further information about this activity, contact Katie Breznai at breznak@ccf.org